BMY congressional trades
Bristol-Myers Squibb Company Common Stock (BMY) appears in 19 congressional disclosure rows from 10 members of Congress in 2025–2026 periodic reports: 7 purchases and 12 sales, with trade dates from Oct 23, 2024 to May 7, 2026. Julie Johnson reported the most, with 5 rows. The median gap between trade date and filing date is 33 days, and 5 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live BMY portfolio or a trading signal.
- 19
- 10
- 7 / 12
- $47K to $355K
- sum of reported ranges
- 2026-05-07
Verified BMY congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 7 purchases and 12 sales. Reported owners: Spouse, Self, Joint. Transaction dates run from 2024-10-23 to 2026-05-07.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Mike Kelly | Bristol-Myers Squibb Company Common Stock | Sale | Spouse | $15,001 - $50,000 | #20034767 Filed 2026-06-11 | |
| Alan Armstrong | Bristol-Myers Squibb Company Common Stock | Purchase | Self | $1,001 - $15,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Gilbert Cisneros | Bristol-Myers Squibb Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20033762 Filed 2026-01-12 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20033789 Filed 2026-01-15 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20033611 Filed 2025-12-11 | |
| Gilbert Cisneros | Bristol-Myers Squibb Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20033619 Filed 2025-12-15 | |
| Gilbert Cisneros | Bristol-Myers Squibb Company Common Stock | Sale | Self | $1,001 - $15,000 | #20033455 Filed 2025-11-18 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20032066 Filed 2025-09-11 | |
| Virginia Foxx | Bristol-Myers Squibb Company Common Stock | Sale | Self | $1,001 - $15,000 | #20030587 Filed 2025-07-03 | |
| Jefferson Shreve | Bristol-Myers Squibb Company Common Stock | Sale | Self | $15,001 - $50,000 | #20030387 Filed 2025-06-22 | |
| Julia Letlow | Bristol-Myers Squibb Company Common Stock | Sale | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Tommy Tuberville | Bristol-Myers Squibb Company | Sale | Self | $1,001 - $15,000 | #014817f0-9809-457f-8ac5-048948608e02 Filed 2026-08-05 | |
| Tommy Tuberville | Bristol-Myers Squibb Company | Sale | Self | $1,001 - $15,000 | #63e4a2b1-5bfc-43b6-b952-ba54e377212c Filed 2025-05-15 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20030296 Filed 2025-05-14 | |
| Greg Landsman | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20029084 Filed 2025-04-08 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Purchase | Joint | $1,001 - $15,000 | #20026762 Filed 2025-02-12 | |
| Virginia Foxx | Bristol-Myers Squibb Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20026516 Filed 2025-01-06 | |
| Valerie Hoyle | Bristol-Myers Squibb Company Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 | |
| Julia Letlow | Bristol-Myers Squibb Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
BMY disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Julie Johnson's BMY trades | 5 | 1 | 4 | 2025-12-18 |
| Gilbert Cisneros's BMY trades | 3 | 2 | 1 | 2025-12-19 |
| Julia Letlow | 2 | 1 | 1 | 2025-04-28 |
| Tommy Tuberville | 2 | 0 | 2 | 2025-04-15 |
| Virginia Foxx | 2 | 1 | 1 | 2025-06-24 |
| Alan Armstrong | 1 | 1 | 0 | 2026-03-27 |
| Greg Landsman | 1 | 0 | 1 | 2025-03-27 |
| Jefferson Shreve | 1 | 0 | 1 | 2025-05-12 |
| Mike Kelly | 1 | 0 | 1 | 2026-05-07 |
| Valerie Hoyle | 1 | 1 | 0 | 2024-10-29 |
How long disclosure took
Days from trade date to filing date for 19 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 2
- 16–30 days
- 6
- 31–45 days
- 6
- Over 45 days
- 5
- Median / longest
- 33d / 477d
Source documents
18 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #014817f0-9809-457f-8ac5-048948608e02Filed 2026-08-05 · 1 row
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 1 row
- #20034767Filed 2026-06-11 · 1 row
- #20033789Filed 2026-01-15 · 1 row
- #20030977Filed 2026-01-13 · 2 rows
- #20033762Filed 2026-01-12 · 1 row
- #20033619Filed 2025-12-15 · 1 row
- #20033611Filed 2025-12-11 · 1 row
- #20033455Filed 2025-11-18 · 1 row
- #20032070Filed 2025-09-12 · 1 row
- #20032066Filed 2025-09-11 · 1 row
- #20030587Filed 2025-07-03 · 1 row
6 older filings are linked from the transaction table.
What BMY filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
- Start here: how Yield Theory approaches research
Yield Theory is independent stock research for people investing their own money. Here is what's free, what members get, and three pieces to read first.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
BMY congressional trades: FAQ
Who in Congress traded BMY?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 19 verified BMY rows from 10 members: Alan Armstrong, Gilbert Cisneros, Greg Landsman, Jefferson Shreve, and 6 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current BMY holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are BMY amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $15,001 - $50,000; $1,001 - $15,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is BMY congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (178 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded BMY.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-11-03. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported BMY and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included